Vensemaglutide

Approval Year

Name

Type

Language

5-37-Glucagon-like peptide I (human), 5-glycine-6-[N-[2-[[(4S)-4-carboxy-4-[(15-carboxy-1-oxopentadecyl)amino]-1-oxobutyl]amino]ethyl]glycine]-8-(2-methylalanine)-26-[N6-[N-(17-carboxy-1-oxoheptadecyl)-L-?-glutamyl-2-[2-(2-aminoethoxy)ethoxy]acetyl-2-[2-

Preferred Name

English

Vensemaglutide

Official Name

English

N2.2 -{2-[(4S)-4-carboxy-4-(15-carboxypentadecanamido)butanamido]ethyl}-N6.22 -[(22S)-22,40-dicarboxy-10,19,24-trioxo-3,6,12,15-tetraoxa-9,18,23-triazatetracontan-1-oyl]-[E 5 >G,R6<s/up> >G,A 8 >Aib,K 34 >

Common Name

English

vensemaglutide [INN]

Common Name

English

Code System Code Type Description

INN

13105

Created by admin on Wed Apr 02 20:13:00 GMT 2025 , Edited by admin on Wed Apr 02 20:13:00 GMT 2025

PRIMARY

CAS

2919344-88-8

Created by admin on Wed Apr 02 20:13:00 GMT 2025 , Edited by admin on Wed Apr 02 20:13:00 GMT 2025

PRIMARY

NCI_THESAURUS

C211812

Created by admin on Wed Apr 02 20:13:00 GMT 2025 , Edited by admin on Wed Apr 02 20:13:00 GMT 2025

PRIMARY

FDA UNII

USR5C76RCA

Created by admin on Wed Apr 02 20:13:00 GMT 2025 , Edited by admin on Wed Apr 02 20:13:00 GMT 2025

PRIMARY

ACTIVE MOIETY


					USR5C76RCA

Vensemaglutide